Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

235 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of anakinra and tocilizumab in management of severe COVID-19: a retrospective cohort study.
Küçükşahin O, Erden A, Karakaş Ö, Güven SC, Armağan B, Şahiner EŞ, İnan O, Kurtipek AC, Gemcioğlu E, Karaahmetoğlu S, Turan S, İzdeş S, Erdem D, Aypak A, Ayhan M, Akıncı E, Bodur H, Güner R, Omma A, Ateş İ. Küçükşahin O, et al. Among authors: ates i. Turk J Med Sci. 2022 Oct;52(5):1486-1494. doi: 10.55730/1300-0144.5487. Epub 2022 Oct 19. Turk J Med Sci. 2022. PMID: 36422492 Free PMC article.
A sensitive indicator for the severity of COVID-19: thiol.
Erel Ö, Neşelioğlu S, Ergin Tunçay M, Fırat Oğuz E, Eren F, Akkuş MS, Güner HR, Ateş İ. Erel Ö, et al. Among authors: ates i. Turk J Med Sci. 2021 Jun 28;51(3):921-928. doi: 10.3906/sag-2011-139. Turk J Med Sci. 2021. PMID: 33306332 Free PMC article.
Comparing ICU admission rates of mild/moderate COVID-19 patients treated with hydroxychloroquine, favipiravir, and hydroxychloroquine plus favipiravir.
Guner R, Hasanoglu I, Kayaaslan B, Aypak A, Akinci E, Bodur H, Eser F, Kaya Kalem A, Kucuksahin O, Ates I, Bastug A, Tezer Tekce Y, Bilgic Z, Gursoy FM, Akca HN, Izdes S, Erdem D, Asfuroglu E, Hezer H, Kilic H, Cıvak M, Aydogan S, Buzgan T. Guner R, et al. Among authors: ates i. J Infect Public Health. 2021 Mar;14(3):365-370. doi: 10.1016/j.jiph.2020.12.017. Epub 2020 Dec 29. J Infect Public Health. 2021. PMID: 33647553 Free PMC article.
Which hematological markers have predictive value as early indicators of severe COVID-19 cases in the emergency department?
Şan İ, Gemcioğlu E, Davutoğlu M, Çatalbaş R, Karabuğa B, Kaptan E, Erden A, Küçükşahin O, Ateş İ, Karaahmetoğlu S, Hasanoğlu İ, İnan O, Ünal BN, Erdemir E, Kahraman FA, Güner R. Şan İ, et al. Among authors: ates i. Turk J Med Sci. 2021 Dec 13;51(6):2810-2821. doi: 10.3906/sag-2008-6. Turk J Med Sci. 2021. PMID: 33726485 Free PMC article.
A single center experience of intravenous immunoglobulin treatment in Covid-19.
Omma A, Erden A, Armağan B, Güven SC, Karakaş Ö, Şahiner ES, Erdem D, İzdeş S, Ateş İ, Küçükşahin O. Omma A, et al. Among authors: ates i. Int Immunopharmacol. 2021 Sep;98:107891. doi: 10.1016/j.intimp.2021.107891. Epub 2021 Jun 14. Int Immunopharmacol. 2021. PMID: 34153671 Free PMC article.
235 results